Cigna Group (NYSE:CI) Given Consensus Rating of “Moderate Buy” by Analysts

Shares of Cigna Group (NYSE:CI) have received a consensus rating of “Moderate Buy” from the twenty-two analysts that are presently covering the firm, Marketbeat.com reports. Six analysts have rated the stock with a hold recommendation, fifteen have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year target price among brokers that have issued ratings on the stock in the last year is $338.30.

CI has been the topic of a number of research analyst reports. Piper Sandler decreased their price target on shares of Cigna Group from $370.00 to $346.00 and set an “overweight” rating on the stock in a report on Wednesday, June 3rd. The Goldman Sachs Group increased their price target on shares of Cigna Group from $335.00 to $340.00 and gave the stock a “buy” rating in a report on Monday, May 4th. Barclays lowered shares of Cigna Group from an “overweight” rating to an “equal weight” rating and decreased their price target for the stock from $310.00 to $304.00 in a report on Tuesday, May 26th. Robert W. Baird set a $337.00 price objective on shares of Cigna Group in a research note on Friday, May 1st. Finally, Morgan Stanley upped their price objective on shares of Cigna Group from $355.00 to $361.00 and gave the company an “overweight” rating in a research note on Wednesday, May 20th.

Cigna Group Price Performance

Shares of NYSE:CI opened at $279.63 on Monday. The company’s fifty day moving average price is $283.79 and its 200-day moving average price is $278.36. The firm has a market capitalization of $73.97 billion, a price-to-earnings ratio of 11.85, a PEG ratio of 1.08 and a beta of 0.28. Cigna Group has a one year low of $239.51 and a one year high of $338.89. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.73 and a quick ratio of 0.73.

Cigna Group (NYSE:CI) last issued its quarterly earnings results on Thursday, April 30th. The health services provider reported $7.79 EPS for the quarter, topping analysts’ consensus estimates of $7.60 by $0.19. The firm had revenue of $68.52 billion for the quarter, compared to analyst estimates of $66.29 billion. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The business’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $6.74 EPS. Cigna Group has set its FY 2026 guidance at 30.350- EPS. On average, equities research analysts anticipate that Cigna Group will post 30.39 earnings per share for the current fiscal year.

Cigna Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, June 18th. Stockholders of record on Thursday, June 4th were paid a $1.56 dividend. The ex-dividend date of this dividend was Thursday, June 4th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. Cigna Group’s dividend payout ratio is 26.45%.

Insiders Place Their Bets

In other news, CEO David Cordani sold 201,878 shares of the company’s stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total value of $59,113,915.96. Following the completion of the sale, the chief executive officer owned 34,337 shares of the company’s stock, valued at approximately $10,054,560.34. This represents a 85.46% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the company’s stock in a transaction on Friday, June 12th. The shares were sold at an average price of $298.61, for a total transaction of $268,450.39. Following the completion of the sale, the chief accounting officer directly owned 2,368 shares of the company’s stock, valued at $707,108.48. This trade represents a 27.52% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.60% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Cigna Group

A number of institutional investors have recently made changes to their positions in the business. Wilkerson Advisory Group LLC purchased a new stake in Cigna Group during the 4th quarter valued at $25,000. Beacon Financial Strategies CORP purchased a new stake in Cigna Group during the 4th quarter valued at $28,000. Kemnay Advisory Services Inc. purchased a new stake in Cigna Group during the 4th quarter valued at $29,000. Prosperity Bancshares Inc purchased a new stake in Cigna Group during the 4th quarter valued at $29,000. Finally, Cedar Mountain Advisors LLC boosted its position in Cigna Group by 161.9% during the 1st quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock valued at $29,000 after buying an additional 68 shares during the period. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.